Match each clinical scenario describing a patient with a substance use disorder to the most appropriate pharmacologic intervention for their long-term management.
- A 45-year-old man with alcohol use disorder and decompensated cirrhosis (Child-Pugh class C) who recently completed medical detoxification and desires medication to reduce cravings.Acamprosate
- A 29-year-old woman with severe co-occurring alcohol and opioid use disorders who completed medical detoxification from all substances 18 days ago and seeks a single medication to prevent relapse of both disorders.Naltrexone
- A 34-year-old pregnant woman at 12 weeks gestation with severe opioid use disorder who is experiencing active withdrawal. She seeks treatment that can be prescribed and managed by her specially waivered outpatient obstetrician.Buprenorphine
- A 52-year-old man with alcohol use disorder who is highly motivated to maintain abstinence. He requests a daily medication that will induce a severe physical reaction, including palpitations and flushing, if he consumes any alcohol.Disulfiram
Cevap
The clinical scenarios correctly match with Acamprosate for the patient with decompensated cirrhosis, Naltrexone for the patient with dual alcohol and opioid use disorders, Buprenorphine for the pregnant patient seeking office-based treatment, and Disulfiram for the patient seeking aversion therapy.
Each clinical scenario presents a unique medical constraint or requirement that dictates the specific pharmacotherapy for substance use disorder management. The correct matches perfectly align the patient's medical comorbidities, dual diagnoses, prescribing setting restrictions, and personal preferences with the distinct pharmacokinetic and pharmacodynamic profiles of acamprosate, naltrexone, buprenorphine, and disulfiram.
Adım Adım Çözüm
Anahtar Kavram
Pharmacotherapy selection for substance use disorders must be individualized based on medical comorbidities, specific patient needs, and regulatory treatment settings.